
SGN-2FF
CAS No. 2089647-47-0
SGN-2FF ( —— )
产品货号. M26438 CAS No. 2089647-47-0
SGN-2FF 是一种口服岩藻糖基转移酶抑制剂,具有抗肿瘤活性。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1320 | 有现货 |
![]() ![]() |
10MG | ¥2341 | 有现货 |
![]() ![]() |
25MG | ¥4682 | 有现货 |
![]() ![]() |
50MG | ¥6383 | 有现货 |
![]() ![]() |
100MG | ¥9072 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称SGN-2FF
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SGN-2FF 是一种口服岩藻糖基转移酶抑制剂,具有抗肿瘤活性。
-
产品描述SGN-2FF is an oral fucosyltransferase inhibitor with antitumor activity.(In Vitro):SGN-2FF is a fucosylation inhibitor, SGN-2FF inhibits cellular fucosylation by depleting the fucosylation substrate GDP-fucose, and by direct inhibition of fucosyltransferases, and leads to the production of fucosylated glycoproteins including antibodies. SGN-2FF activates human T cells in an antigen-dependent manner.(In Vivo):In multiple mouse tumor models, SGN-2FF exhibits antitumor activity. SGN-2FF shows substantial tumor growth delay. SGN-2FF elevates the protective effect of a lymphoma vaccine in a syngeneic mouse model.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Telomerase
-
研究领域——
-
适应症——
化学信息
-
CAS Number2089647-47-0
-
分子量166.148
-
分子式C6H11FO4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (300.93 mM)
-
SMILESC[C@@H]1OC(O)[C@@H](F)[C@H](O)[C@@H]1O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Quan Wang J, et al. Discovery of new chromen-4-one derivatives as telomerase inhibitors through regulating expression of dyskerin. J Enzyme Inhib Med Chem. 2018 Dec;33(1):1199-1211.
产品手册




关联产品
-
Sodium pyruvate
丙酮酸钠是一种抗氧化剂,可用于治疗慢性阻塞性肺病。
-
siegesmethyethericac...
Siegesmethyletheric acid 是从 Siegesbeckia orientalis L. (菊科) 的乙酸乙酯馏分中分离出的。
-
Budipine
Budipine 是一种低亲和力的 N-甲基-D-天冬氨酸受体拮抗剂,是一种抗帕金森病化合物。